Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy.
about
Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphomaRelationship and interactions of curcumin with radiation therapySecond malignant neoplasms and cardiovascular disease following radiotherapy.Pediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine.Radiation-induced breast angiosarcoma: a case reportThe value of FATS expression in predicting sensitivity to radiotherapy in breast cancerBreast cancer after chest radiation therapy for childhood cancer.Role of Radiotherapy in Modern Treatment of Hodgkin's LymphomaRisk of second breast cancer in female Hodgkin's lymphoma survivors: a meta-analysis.Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031Pediatric Hodgkin lymphoma: trade-offs between short- and long-term mortality risksPrimary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?Long-term outcomes in patients with early stage nodular lymphocyte-predominant Hodgkin's lymphoma treated with radiotherapy.Secondary Malignancies Following Treatment for Hodgkin's Lymphoma in Childhood and AdolescenceAn increased incidence of Hodgkin's lymphoma in patients with adult-onset sarcoma.Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology GroupRisk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study.Impact of low-dose involved-field radiation therapy on pediatric patients with lymphocyte-predominant Hodgkin lymphoma treated with chemotherapy: a report from the Children's Oncology Group.Second malignant neoplasms following radiotherapy.Long-term survivorship at a price: late-term, therapy-associated toxicities in the adult hodgkin lymphoma patient.Effect of Akimbo versus Raised Arm Positioning on Breast and Cardiopulmonary Dosimetry in Pediatric Hodgkin LymphomaMinimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology GroupBreast cancer in young women after treatment for Hodgkin's disease during childhood or adolescence--an observational study with up to 33-year follow-up.State-of-the-art issues in Hodgkin's lymphoma survivorship.Can low-risk, early-stage patients with Hodgkin lymphoma be spared radiotherapy?Chemotherapy only for localized Hodgkin lymphoma.Management of children with high-risk Hodgkin lymphoma.Modern management of lymphocyte-predominant Hodgkin lymphoma.Controversies in the role of radiotherapy in the treatment of pediatric Hodgkin lymphoma.Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy (IMRT).The cancer is over, now what?: Understanding risk, changing outcomes.A population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphoma.Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer.Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial.Effect of chemotherapy alone with adult chemotherapy regimens on prognosis of children and adolescents with Hodgkin's disease.Long-term structured follow-up is essential after curative cancer treatmentDose Response of MTLn3 Cells to Serial Dilutions of Arsenic Trioxide and Ionizing Radiation.Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation.Increasing incidence of thyroid cancer in Great Britain, 1976-2005: age-period-cohort analysis.Synchronous Hodgkin lymphoma and gastric adenocarcinoma: A rare case report and literature review.
P2860
Q24632704-BE43D901-7FCA-4251-AC94-73AC3A1000BDQ26746150-E728BE84-8E9F-476E-AC38-1CD66C50CC67Q26864522-6DD54BC4-B2C5-4895-868E-B8D0B04E98B0Q30248284-0D6FEA50-0CB8-4516-B656-E0961FA2E0E7Q30365517-CDC87020-9CF2-4E55-BA6A-5E79E4E151A5Q33888843-92CCE9B0-697E-4ED4-B473-81AB946A73E8Q33910979-BCEB7F8F-2DA0-4625-B413-5E4619487D64Q34235785-82CD131B-5A77-4119-84CE-0D7FA5C4E50CQ34284202-711495F0-F60D-4077-8916-B9B255044AC3Q34451778-B14AC0FD-7CB0-49FA-8048-F0613DC7AAEBQ34640709-0F74C907-FB6A-4CC7-AE9D-AC6E0B00055DQ34802443-E963C592-38D9-428B-BD9E-AA22B1825862Q34995044-A7E8B1E0-9E93-4CB8-813C-57F2A2E07B43Q35682335-3AD17D7C-2F0C-427C-B610-F8835425FE4BQ35958026-7EA39E50-F709-48CB-9F0C-E98F026B92E7Q36025958-9F38D876-9D60-44C6-99D7-C7BDA8111C4BQ36176997-34C6F87B-85D3-485B-B126-17E718933CE6Q36309989-E782E915-9FCF-49EB-89BE-3E09ADE558D4Q36538754-F6E20337-B74A-4EDE-AC02-6D51CF3D71B0Q36612560-790E6DB1-1040-43F3-AE6B-7A1FA80D30CBQ37124918-3F31F988-8624-40DD-A332-E95DC22CF057Q37169352-D394FBBE-20C8-4E1A-B6AC-86993A94368FQ37627536-D4BF9B42-C5C6-49D7-A1D9-735392EF19A3Q37782029-9CB1D880-943E-4636-8D4D-80237295AC63Q37866673-BB3D8906-433B-46B1-AB71-228B6EDCAF13Q37888802-C9634F00-1A24-4C4F-942D-1BF5C91BB94BQ37970408-AF553CAF-959D-453D-8ED2-161769E77867Q38080591-FB0C27FE-6E2E-4E88-8062-61A6C25A68B7Q38131410-855B0EC8-E7B5-4691-954E-F26A1B9672B4Q38261288-981FBAE9-1F04-48A6-AE34-157F89ECA9A1Q39749166-957E5794-0E8C-460F-A1CF-6B159BE4E170Q40061559-F20E1E78-9DD7-40F7-816D-B5BF62105FBDQ40148445-EA7964A3-9910-45FA-BB73-3678CCEE1844Q40465014-FB54A20F-CB17-4FDE-876D-89EDDA1ECE25Q40762228-D36235AE-9F1D-496D-A20D-CAB4FD28609DQ42415999-C6FAF38D-426A-47C1-B9ED-4EB12D102B4AQ43242926-710C5AC6-1C3B-4ACE-B824-80B9E9E5D4FDQ46213781-E2FAF81C-AA40-48FA-812C-A1CB928BE78CQ47421685-EDF89695-698E-4F0C-8C99-48C5681F03F7Q49636510-5EFDABAF-5C9C-4526-BD4F-A1B8167A5D90
P2860
Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Second malignant neoplasms in ...... se radiation and chemotherapy.
@en
type
label
Second malignant neoplasms in ...... se radiation and chemotherapy.
@en
prefLabel
Second malignant neoplasms in ...... se radiation and chemotherapy.
@en
P2093
P2860
P356
P1476
Second malignant neoplasms in ...... se radiation and chemotherapy.
@en
P2093
Alice S Whittemore
Maureen M O'Brien
Michael P Link
Raymond R Balise
Sarah S Donaldson
P2860
P304
P356
10.1200/JCO.2009.24.8062
P407
P577
2010-02-01T00:00:00Z